← Back to Search

Immunomodulator

Abatacept for Rheumatoid Arthritis

Phase 4
Waitlist Available
Led By Kwanghoon Han, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 24
Awards & highlights

Study Summary

This study is evaluating whether baseline levels of T cell associated biomarkers predict efficacy of abatacept during 24 weeks of treatment in patients with moderate to severe active Rheumatoid Arthritis (RA) who have had an inadequate response to conventional disease

Eligible Conditions
  • Rheumatoid Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
American College of Rheumatology (ACR) 20 Response at Week 14
Secondary outcome measures
ACR20 Response at Week 24
ACR50 Response at Week 24
ACR70 Response at Week 24
+1 more

Side effects data

From 2023 Phase 3 trial • 613 Patients • NCT03086343
6%
URINARY TRACT INFECTION
5%
UPPER RESPIRATORY TRACT INFECTION
5%
NASOPHARYNGITIS
3%
HYPERTENSION
100%
80%
60%
40%
20%
0%
Study treatment Arm
Abatacept
Upadacitinib 15 mg

Trial Design

1Treatment groups
Experimental Treatment
Group I: AbataceptExperimental Treatment1 Intervention
Abatacept 125mg subcutaneous injection weekly for 24 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Abatacept
FDA approved

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,738 Previous Clinical Trials
1,844,326 Total Patients Enrolled
2 Trials studying Rheumatoid Arthritis
326 Patients Enrolled for Rheumatoid Arthritis
Bristol-Myers SquibbIndustry Sponsor
2,638 Previous Clinical Trials
4,128,489 Total Patients Enrolled
108 Trials studying Rheumatoid Arthritis
371,515 Patients Enrolled for Rheumatoid Arthritis
Kwanghoon Han, MDPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis
Kwanghoon (Bobby) Han 2019. "A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03882008.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top